Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
J Am Acad Dermatol. 2011 Nov;65(5):1048.e1-22. doi: 10.1016/j.jaad.2010.08.034. Epub 2011 May 12.
Topical use of systemic agents to treat cutaneous disorders is widely applied. However, there is a lack of articles summarizing the relevant literature in a systematic way.
We sought to review the published literature regarding topical use of systemic drugs that were categorized according to their mode of actions. Only drugs that are not yet commercially available in a topical preparation are included.
A PubMed search was performed, using as key words "topical," "extemporaneous," "compounding," and names of each generic drug, to identify all clinical reports (1966-2009).
Although many systemic drugs are used topically, randomized controlled trials were limited to a few agents.
Many of the reports consist only of small case series or are anecdotal in nature. As the level of evidence is limited, larger prospective trials are needed before firm conclusions can be drawn.
Extemporaneous compounding helps physicians to individualize treatment to the patient's specific needs and to create topical preparations that are not otherwise commercially available. However, comparative effectiveness studies are needed to determine whether or not topical use of systemic therapeutics is more beneficial than existing therapies.
局部应用全身用药物治疗皮肤疾病的方法得到广泛应用。然而,目前缺乏系统地总结相关文献的文章。
我们旨在对已发表的文献进行综述,这些文献涉及根据作用机制分类的局部应用全身用药物。我们仅纳入尚未以局部制剂形式上市的药物。
检索 PubMed 数据库,使用“局部”“临时制剂”“配制”和每种通用药物的名称作为关键词,以确定所有临床报告(1966-2009 年)。
尽管许多全身用药物被局部应用,但随机对照试验仅局限于少数几种药物。
许多报告仅为小病例系列或属于轶事报告。由于证据水平有限,在得出确切结论之前,需要进行更大规模的前瞻性试验。
临时制剂有助于医生根据患者的具体需求进行个体化治疗,并可配制其他途径无法获得的局部制剂。然而,需要进行比较有效性研究,以确定局部应用全身治疗是否比现有治疗更有益。